A carregar...
A case of ramucirumab-related gastrointestinal perforation in gastric cancer with small bowel metastasis
BACKGROUND: Ramucirumab is a monoclonal antibody targeting vascular endothelial growth factor receptor 2 (VEGFR-2). Ramucirumab either alone or in combination with paclitaxel (PTX) has been found to be safe and effective for patients with previously treated advanced gastric cancer. One of the seriou...
Na minha lista:
Publicado no: | Surg Case Rep |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Springer Berlin Heidelberg
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5736507/ https://ncbi.nlm.nih.gov/pubmed/29260338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40792-017-0399-7 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|